🇺🇸 FDA
Patent

US 6084069

Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy

expired A61KA61K38/00

Quick answer

US patent 6084069 (Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jul 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K38/00